Sherbrooke Park Advisers »

Peregrine Pharmaceuticals shares owned by Sherbrooke Park Advisers

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Sherbrooke Park Advisers from 13F filings

Historical chart of Sherbrooke Park Advisers investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Sherbrooke Park Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Sherbrooke Park Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $115k 18k 6.50